Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Forkhead-box A1 suppresses the progression of endometrial cancer via crosstalk with estrogen receptor α.

Wang J, Bao W, Qiu M, Liao Y, Che Q, Yang T, He X, Qiu H, Wan X.

Oncol Rep. 2014 Mar;31(3):1225-34. doi: 10.3892/or.2014.2982. Epub 2014 Jan 20.

PMID:
24452315
[PubMed - indexed for MEDLINE]
2.

FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer.

Qiu M, Bao W, Wang J, Yang T, He X, Liao Y, Wan X.

BMC Cancer. 2014 Feb 11;14:78. doi: 10.1186/1471-2407-14-78.

PMID:
24512546
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells.

Abe Y, Ijichi N, Ikeda K, Kayano H, Horie-Inoue K, Takeda S, Inoue S.

Cancer Sci. 2012 Apr;103(4):806-12. doi: 10.1111/j.1349-7006.2012.02201.x. Epub 2012 Feb 7.

PMID:
22313737
[PubMed - indexed for MEDLINE]
4.

Switch in FOXA1 status associates with endometrial cancer progression.

Tangen IL, Krakstad C, Halle MK, Werner HM, Oyan AM, Kusonmano K, Petersen K, Kalland KH, Akslen LA, Trovik J, Hurtado A, Salvesen HB.

PLoS One. 2014 May 21;9(5):e98069. doi: 10.1371/journal.pone.0098069. eCollection 2014.

PMID:
24849812
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.

Horm Cancer. 2012 Aug;3(4):147-59. doi: 10.1007/s12672-012-0111-0. Epub 2012 Apr 3.

PMID:
22476979
[PubMed - indexed for MEDLINE]
6.

MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.

Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y, Yin LR.

FEBS J. 2013 Aug;280(16):3768-79. doi: 10.1111/febs.12365. Epub 2013 Jun 27.

PMID:
23731275
[PubMed - indexed for MEDLINE]
7.

TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma.

Gu Z, Ding G, Liang K, Zhang H, Guo G, Zhang L, Cui J.

Med Sci Monit. 2014 Jun 14;20:980-7. doi: 10.12659/MSM.890544.

PMID:
24929083
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

RPRD1B promotes tumor growth by accelerating the cell cycle in endometrial cancer.

Wang Y, Qiu H, Hu W, Li S, Yu J.

Oncol Rep. 2014 Mar;31(3):1389-95. doi: 10.3892/or.2014.2990. Epub 2014 Jan 21.

PMID:
24452636
[PubMed - indexed for MEDLINE]
9.

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.

Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, Li PC, Lin SH, Hu MC.

Breast Cancer Res. 2008;10(1):R21. doi: 10.1186/bcr1872. Epub 2008 Feb 29.

PMID:
18312651
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma.

Chen X, Yan Q, Li S, Zhou L, Yang H, Yang Y, Liu X, Wan X.

Cancer Lett. 2012 Jan 1;314(1):41-53. doi: 10.1016/j.canlet.2011.09.014. Epub 2011 Sep 21.

PMID:
21983130
[PubMed - indexed for MEDLINE]
11.

A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells.

Bao W, Wang HH, Tian FJ, He XY, Qiu MT, Wang JY, Zhang HJ, Wang LH, Wan XP.

Mol Cancer. 2013 Dec 9;12:155. doi: 10.1186/1476-4598-12-155.

PMID:
24321270
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

miR-22 inhibits proliferation and invasion in estrogen receptor α-positive endometrial endometrioid carcinomas cells.

Li S, Hu R, Wang C, Guo F, Li X, Wang S.

Mol Med Rep. 2014 Jun;9(6):2393-9. doi: 10.3892/mmr.2014.2123. Epub 2014 Apr 8.

PMID:
24715036
[PubMed - indexed for MEDLINE]
13.

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.

PMID:
18037662
[PubMed - indexed for MEDLINE]
14.

FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer.

Wolf I, Bose S, Williamson EA, Miller CW, Karlan BY, Koeffler HP.

Int J Cancer. 2007 Mar 1;120(5):1013-22.

PMID:
17163418
[PubMed - indexed for MEDLINE]
15.

Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.

Zhang SQ, Cai B, Liu L, He YY, Yang YX, Wan XP.

Int J Gynecol Cancer. 2009 Nov;19(8):1377-83. doi: 10.1111/IGC.0b013e3181a83e1a.

PMID:
20009893
[PubMed - indexed for MEDLINE]
16.

The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.

Zannoni GF, Monterossi G, De Stefano I, Gargini A, Salerno MG, Farulla I, Travaglia D, Vellone VG, Scambia G, Gallo D.

Hum Pathol. 2013 Jun;44(6):1047-54. doi: 10.1016/j.humpath.2012.09.007. Epub 2012 Dec 21.

PMID:
23266443
[PubMed - indexed for MEDLINE]
17.

Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.

Yang T, Qiu H, Bao W, Li B, Lu C, Du G, Luo X, Wang L, Wan X.

PLoS One. 2013 Jun 28;8(6):e67458. doi: 10.1371/journal.pone.0067458. Print 2013.

PMID:
23840707
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Estrogen-related receptor-γ regulates estrogen receptor-α responsiveness in uterine endometrial cancer.

Yamamoto T, Mori T, Sawada M, Kuroboshi H, Tatsumi H, Yoshioka T, Matsushima H, Iwasaku K, Kitawaki J.

Int J Gynecol Cancer. 2012 Nov;22(9):1509-16. doi: 10.1097/IGC.0b013e31826fd623.

PMID:
23051957
[PubMed - indexed for MEDLINE]
19.

Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.

Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH.

Cancer Res. 2003 Oct 1;63(19):6195-9.

PMID:
14559803
[PubMed - indexed for MEDLINE]
Free Article
20.

Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice.

Vilgelm A, Lian Z, Wang H, Beauparlant SL, Klein-Szanto A, Ellenson LH, Di Cristofano A.

Cancer Res. 2006 Apr 1;66(7):3375-80.

PMID:
16585156
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk